Progression of Alzheimer's disease: variability and consistency: ontogenic models, their applicability and relevance
- PMID: 9850911
- DOI: 10.1007/978-3-7091-7508-8_2
Progression of Alzheimer's disease: variability and consistency: ontogenic models, their applicability and relevance
Abstract
Much has been learned about the clinical symptomatology of Alzheimer's disease (AD) and ontogenic reciprocal relationships in the past few decades. It is now possible to describe and verify inexorable symptomatic sequences and corresponding temporal relationships. It is also possible to identify more variable symptoms in AD. Ontogenic models can be useful in providing a clearer understanding of the nature of AD symptomatology in terms of both consistency and variability. These models can also be informative in explicating the management needs of AD patients and the treatment possibilities of AD symptoms as well as the etiology of variability in AD symptoms.
Similar articles
-
The comparison of cognitive and functional performance in children and Alzheimer's disease supports the retrogenesis model.J Alzheimers Dis. 2013;33(1):191-203. doi: 10.3233/JAD-2012-121123. J Alzheimers Dis. 2013. PMID: 22948284
-
Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: management and treatment import.Am J Alzheimers Dis Other Demen. 2002 Jul-Aug;17(4):202-12. doi: 10.1177/153331750201700411. Am J Alzheimers Dis Other Demen. 2002. PMID: 12184509 Free PMC article.
-
Rate of progression of Alzheimer's disease is associated with genetic risk.Arch Neurol. 1995 Sep;52(9):918-23. doi: 10.1001/archneur.1995.00540330100021. Arch Neurol. 1995. PMID: 7661731
-
The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease.J Neural Transm Suppl. 1998;54:117-27. doi: 10.1007/978-3-7091-7508-8_11. J Neural Transm Suppl. 1998. PMID: 9850920 Review.
-
Molecular biology of Alzheimer's dementia and its clinical relevance to early diagnosis and new therapeutic strategies.Gerontology. 2001 Mar-Apr;47(2):65-71. doi: 10.1159/000052775. Gerontology. 2001. PMID: 11287729 Review.
Cited by
-
Correlation Between Montreal Cognitive Assessment and Functional Outcome in Subacute Stroke Patients With Cognitive Dysfunction.Ann Rehabil Med. 2018 Feb;42(1):26-34. doi: 10.5535/arm.2018.42.1.26. Epub 2018 Feb 28. Ann Rehabil Med. 2018. PMID: 29560321 Free PMC article.
-
From Alzheimer's disease retrogenesis: a new care strategy for patients with advanced dementia.Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):483-9. doi: 10.1177/1533317512459794. Epub 2012 Sep 13. Am J Alzheimers Dis Other Demen. 2012. PMID: 22984089 Free PMC article. Clinical Trial.
-
Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism.Neuropsychiatr Dis Treat. 2008 Aug;4(4):715-22. doi: 10.2147/ndt.s3268. Neuropsychiatr Dis Treat. 2008. PMID: 19043515 Free PMC article.
-
The Implementation of Infant Anoesis and Adult Autonoesis in the Retrogenesis and Staging System of the Neurocognitive Disorders: A Proposal for a Multidimensional Person-Centered Model.Geriatrics (Basel). 2025 Feb 2;10(1):20. doi: 10.3390/geriatrics10010020. Geriatrics (Basel). 2025. PMID: 39997519 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical
Miscellaneous